Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Exact Sciences Corp (EXAS)  
$101.63 0.02 (0.02%) as of 4:30 Wed 1/7


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 185,000,000
Market Cap: 18.80(B)
Last Volume: 2,612,944 Avg Vol: 2,248,633
52 Week Range: $40.31 - $101.93
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    NASDAQ COMPOSITE     NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  64
Guru Rank Value     : 12.4
Guru Occurances    : 3

 

            6 Months   1 Year   2 Year  
 
Company Profile   Exact Sciences is a cancer screening and diagnostics company. Co.'s primary screening product, the Cologuard® test, is a non-invasive stool-based DNA screening test that utilizes a multi-target approach to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. Co.'s portfolio of Oncotype tests include: Oncotype DX gene expression tests for breast, prostate and colon cancers; Oncotype DX AR-V7 Nucleus Detect® test, a liquid-based test for advanced stage prostate cancer; and Oncotype MAP™ Pan-Cancer Tissue test (oncomap test), a test delivering tumor profiling to aid therapy selection for patients with metastatic, refractory or recurrent cancer.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 19,500
Total Buy Value $0 $0 $0 $1,001,325
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 25,858 27,343 30,550 135,927
Total Sell Value $1,740,409 $1,802,809 $1,973,421 $8,322,784
Total People Sold 5 5 5 11
Total Sell Transactions 7 8 9 60
End Date 2025-10-09 2025-07-08 2025-01-07 2024-01-08

   
Records found: 803
  Page 1 of 33  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Baranick Brian EVP, GM, Precision Oncology   •       –      –    2025-12-24 4 D $101.59 $1,517,551 D/D (14,938) 103,874     -
   Baranick Brian EVP, GM, Precision Oncology   •       –      –    2025-12-24 4 A $0.00 $0 D/D 29,416 118,812     -
   Orville Jacob A EVP, GM, Screening   •       –      –    2025-12-23 4 D $101.82 $6,968,255 D/D (68,437) 100,403     -
   Orville Jacob A EVP, GM, Screening   •       –      –    2025-12-23 4 A $0.00 $0 D/D 72,523 104,829     -
   Orville Jacob A EVP, GM, Screening   •       –      –    2025-12-23 4 OE $0.00 $0 D/D 73,080 69,511     -
   Condella Sarah EVP, Human Resources   •       –      –    2025-12-23 4 D $101.82 $4,270,127 D/D (41,938) 129,134     -
   Condella Sarah EVP, Human Resources   •       –      –    2025-12-23 4 A $0.00 $0 D/D 42,018 132,894     -
   Condella Sarah EVP, Human Resources   •       –      –    2025-12-23 4 OE $0.00 $0 D/D 47,208 118,059     -
   Baranick Brian EVP, GM, Precision Oncology   •       –      –    2025-12-23 4 D $101.82 $7,041,769 D/D (69,159) 89,396     -
   Baranick Brian EVP, GM, Precision Oncology   •       –      –    2025-12-23 4 A $0.00 $0 D/D 63,107 99,849     -
   Baranick Brian EVP, GM, Precision Oncology   •       –      –    2025-12-23 4 OE $0.00 $0 D/D 73,080 66,487     -
   Conroy Kevin T President and CEO   •       •      –    2025-12-23 4 D $101.82 $34,165,599 D/D (335,549) 1,234,970     -
   Conroy Kevin T President and CEO   •       •      –    2025-12-23 4 A $0.00 $0 D/D 713,931 155,417     -
   Bloomer Aaron EVP, Chief Financial Officer   •       –      –    2025-12-23 4 D $101.82 $2,846,276 D/D (27,954) 48,768     -
   Bloomer Aaron EVP, Chief Financial Officer   •       –      –    2025-12-23 4 OE $0.00 $0 D/D 63,099 59,571     -
   Herriott James SVP, General Counsel & Sec   •       –      –    2025-12-23 4 D $101.82 $5,077,763 D/D (49,870) 67,815     -
   Herriott James SVP, General Counsel & Sec   •       –      –    2025-12-23 4 A $0.00 $0 D/D 72,320 74,933     -
   Herriott James SVP, General Counsel & Sec   •       –      –    2025-12-23 4 OE $0.00 $0 D/D 33,780 32,934     -
   Herriott James SVP, General Counsel & Sec   •       –      –    2025-11-19 4 AS $70.00 $70,000 D/D (1,000) 11,585 18%     
   Orville Jacob A EVP, GM, Screening   •       –      –    2025-11-19 4 AS $75.00 $375,000 D/D (5,000) 23,237 18%     
   Herriott James SVP, General Counsel & Sec   •       –      –    2025-11-04 4 AS $70.08 $105,120 D/D (1,500) 12,585 46%     
   Baranick Brian EVP, GM, Precision Oncology   •       –      –    2025-11-04 4 AS $70.08 $200,289 D/D (2,858) 22,368 46%     
   Napier Katherine S   –       •      –    2025-10-24 4 AS $65.00 $780,000 D/D (12,000) 60,759 57%     
   Doyle James Edward   –       •      –    2025-10-09 4 AS $60.00 $120,000 D/D (2,000) 57,962 71%     
   Herriott James SVP, General Counsel & Sec   •       –      –    2025-10-09 4 AS $60.00 $90,000 D/D (1,500) 14,085 71%     
  803 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 33
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2026 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us